Popular Articles

North Carolina Should Increase Cigarette Tax By 50 Cents To Save Lives And Raise Revenue
The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids:
generic viagra online
Data Presented At Society Of Nuclear Medicine 2009 Annual Meeting Supports Potential Of Peregrine's Cotara(R) For The Treatment Of Brain Cancer
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) reported that researchers will present data at the SNM 2009 Annual Meeting showing that its brain cancer agent Cotara(R) specifically localizes to brain tumors at high concentrations with minimal radiation exposure to other organs. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for glioblastoma multiforme (GBM), a deadly form of brain cancer. The results reported from an ongoing dosimetry study at U.S. brain cancer centers show that in patients dosed in the first two cohorts of the study, the concentration of Cotara in brain tumors was on average more than 300-fold higher than in other normal organs. In addition, these patients have all either met or exceeded the expected median survival time of six months for recurrent GBM patients. Cotara is currently being tested in this Phase I dose response and dosimetry trial and in a Phase II clinical trial in recurrent GBM patients.
News of the day
Screening Prevents Aneurysm Deaths, But Questions Remain Over Cost Effectiveness
The national aortic screening programme in the UK should, in due course, prevent about half of all aneurysm deaths in men over 65 and will be extremely cost effective for the NHS, conclude researchers in a study published on bmj.com. However a second study, also published today, concludes that screening is not cost effective and calls for additional research into the long term outcomes and costs of screening.
Mental Health

Race Disparities Plague Treatment And Outcomes In Health Care

CNN examines race disparities in health care during a 4-minute segment that is part of the station"s week-long focus on health care issues. Anchors Tony Harris and Elizabeth Cohen examine disparities in both treatment and outcomes for minorities. For instance, Cohen notes that if a black man and a white man have a stroke, the black man"s chance of survival is 25 percent compared to 52 percent for a white man. Cohen also points to the death rate from cancer, which is 40 percent higher for black men than for white men. "These are incredible statistics," Cohen says. She points out that without health insurance, a person doesn"t get as good of medical care and their outcomes are worse, noting that "minorities are over represented in the number of people who don"t have insurance." "When I see a report like this... the first thing that I think and often think is that there must be some racism in the system," Harris responds. Cohen then points to research that shows that even with white and black veterans who have the same health insurance, blacks have worse outcomes. She noted other unspecified research that surveyed cardiologists and found that 44 percent believe blacks get worse treatment than whites. Harris ended the discussion noting that presumably getting more people insured would help to close the gap (6/19). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):